Melatonin utility in neonates and children

Journal of the Formosan Medical Association

Volumn 111, Issue 2, 2012, Pages 57-66

  Chen, Yu Chieh ^a   Tain, You Lin ^a   Sheen, Jiunn Ming ^a   Huang, Li Tung ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Antioxidant; Children; Melatonin; Neonates; Sleep disorders

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; PLACEBO;

ANTIOXIDANT ACTIVITY; BODY TEMPERATURE; CHILD; CIRCADIAN RHYTHM; DEVELOPMENTAL DISORDER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INTRACTABLE EPILEPSY; LEUKOMALACIA; LUNG DYSPLASIA; MALNUTRITION; MONOTHERAPY; NEONATAL STRESS; NEWBORN; NEWBORN SEPSIS; NONHUMAN; ONTOGENY; PERIVENTRICULAR LEUKOMALACIA; PLEIOTROPY; PREECLAMPSIA; PREGNANCY; PREMATURITY; PROTEIN SYNTHESIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; RESPIRATORY DISTRESS SYNDROME; REVIEW; SLEEP DISORDER;

ANTIOXIDANTS; CHILD; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MELATONIN; PRE-ECLAMPSIA; PREGNANCY; SEIZURES; SEPSIS; SLEEP DISORDERS;

EID: 84862832315     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.11.024     Document Type: Review

References (96)

1. Radogna F., Diederich M., Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010, 80:1844-1852.
2. Hardeland R., Cardinali D.P., Srinivasan V., Spence D.W., Brown G.M., Pandi-Perumal S.R. Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 2011, 93:350-384.
3. Lerner A.B., Case J.D., Takahashi Y. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958, 80:2587.
4. Reiter R.J., Tan D.X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000, 7:444-458.
5. Rodriguez C., Mayo J.C., Sainz R.M., Antolín I., Herrera F., Martín V., et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004, 36:1-9.
6. Reiter R.J., Calvo J.R., Karbownik M., Qi W., Tan D.X. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000, 917:376-386.
7. Mirick D.K., Davis S. Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol Biomarkers Prev 2008, 17:3306-3313.
8. Reiter R.J., Tan D.X., Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 2002, 123:1007-1019.
9. Gitto E., Pellegrino S., Gitto P., Barberi I., Reiter R.J. Oxidative stress of the newborn in the pre- and post-natal period and the clinical utility of melatonin. J Pineal Res 2009, 46:128-139.
10. Gitto E., Aversa S., Reiter R.J., Barberi I., Pellegrino S. Update on the use of melatonin in pediatrics. J Pineal Res 2011, 50:21-28.
11. Aversa S, Pellegrino S, Barberi I, Reiter RJ, Gitto E. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J Matern Fetal Neonatal Med, doi:10.3109/14767058.2011.573827.
12. Harderland R., Poeggeler B. Non-vertebrate melatonin. J Pineal Res 2003, 34:233-241.
13. Acuña-Castroviejo D., Martín M., Macías M., Escames G., León J., Khaldy H., et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001, 30:65-74.
14. Guerrero J.M., Reiter R.J. Melatonin-immune system relationships. Curr Top Med Chem 2002, 2:167-179.
15. Tamura H., Nakamura Y., Terron M.P., Flores L.J., Manchester L.C., Tan D.X., et al. Melatonin and pregnancy in the human. Reprod Toxicol 2008, 25:291-303.
16. Sadowsky D.W., Yellon S., Mitchell M.D., Nathanielsz P.W. Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138-142 days gestation (term = 147 days gestation). Endocrinology 1991, 128:1812-1818.
17. Seron-Ferre M., Torres-Farfan C., Forcelledo M.L., Valenzuela G.J. The development of circadian rhythms in the fetus and neonate. Semin Perinatol 2001, 25:363-370.
18. Arendt J. Melatonin and human rhythms. Chronobiol Int 2006, 23:21-37.
19. Weissbluth M. Melatonin increases guanosine monophosphate: biochemical effects mediated by porphyrins, calcium and nitric oxide. Relationships to infant colic and the sudden infant death syndrome. Med Hypotheses 1994, 42:390-392.
20. Jahnke G., Marr M., Myers C., Wilson R., Travlos G., Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999, 50:271-279.
21. Seabra M.L., Bignotto M., Pinto L.R., Tufik S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000, 29:193-200.
22. Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 2000, 22:213-217.
23. Gitto E., Reiter R.J., Amodio A., Romeo C., Cuzzocrea E., Sabatino G., et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004, 36:250-255.
24. Leach C.M., Thorburn G.D. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. Prostaglandins 1980, 20:51-56.
25. Hoebert M., van der Heijden K.B., van Geijlswijk I.M., Smits M.G. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res 2009, 47:1-7.
26. Jan J.E., Wasdell M.B., Reiter R.J., Weiss M.D., Johnson K.P., Ivanenko A., et al. Melatonin therapy of pediatric sleep disorders: recent advances, why it works, who are the candidates and how to treat. Curr Pediatr Rev 2007, 3:214-224.
27. Sheldon S.H. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998, 351:1254.
28. Walsh S.W. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 1998, 16:93-104.
29. Milczarek R., Hallmann A., Sokołowska E., Kaletha K., Klimek J. Melatonin enhances antioxidant action of alpha-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res 2010, 49:149-155.
30. Nakamura Y., Tamura H., Kashida S., Takayama H., Yamagata Y., Karube A., et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res 2001, 30:29-33.
31. Briceño-Pérez C., Briceño-Sanabria L., Vigil-De Gracia P. Prediction and prevention of preeclampsia. Hypertens Pregnancy 2009, 28:138-155.
32. Fowden A.L., Giussani D.A., Forhead A.J. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda) 2006, 21:29-37.
33. Gupta P., Narang M., Banerjee B.D., Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr 2004, 4:14.
34. Okatani Y., Wakatsuki A., Shinohara K., Kaneda C., Fukaya T. Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res 2001, 30:199-205.
35. Richter H.G., Hansell J.A., Raut S., Giussani D.A. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res 2009, 46:357-364.
36. Gitto E., Reiter R.J., Cordaro S.P., La Rosa M., Chiurazzi P., Trimarchi G., et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 2004, 21:209-216.
37. Gitto E., Reiter R.J., Sabatino G., Buonocore G., Romeo C., Gitto P., et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res 2005, 39:287-293.
38. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003, 62:441-450.
39. Inder T., Mocatta T., Darlow B., Spencer C., Volpe J.J., Winterbourn C. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 2002, 52:213-218.
40. Welin A.K., Svedin P., Lapatto R., Sultan B., Hagberg H., Gressens P., et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007, 61:153-158.
41. Kaur C., Sivakumar V., Ling E.A. Melatonin protects periventricular white matter from damage due to hypoxia. J Pineal Res 2010, 48:185-193.
42. Husson I., Mesples B., Bac P., Vamecq J., Evrard P., Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002, 51:82-92.
43. Saugstad O.D. Oxidative stress in the newborn-A 30-year perspective. Biol Neonate 2005, 88:228-236.
44. Ferriero D.M. Neonatal brain injury. N Engl J Med 2004, 351:1985-1995.
45. Mclean C., Ferriero D. Mechanisms of hypoxic-ischemic injury in the term infant. Semin Perinatol 2004, 28:425-432.
46. Carloni S., Perrone S., Buonocore G., Longini M., Proietti F., Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008, 44:157-164.
47. Signorini C., Ciccoli L., Leoncini S., Carloni S., Perrone S., Comporti M., et al. Free iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 2009, 46:148-154.
48. Perez E.M., Weisman L.E. Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol 1997, 24:213-225.
49. Batra S., Kumar R., Seema, Kapoor A.K., Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Pediatr 2000, 20:27-33.
50. Seema, Kumar R., Mandal R.N., Tandon A., Randhawa V.S., Mehta G., et al. Serum TNF-α and free radical scavengers in neonatal septicaemia. Ind J Pediatr 1999, 66:511-516.
51. Kurt A.N., Aygun A.D., Godekmerdan A., Kurt A., Dogan Y., Yilmaz E. Serum IL-1b, IL-6, IL-8, and TNF-α levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007, 2007:31397.
52. Fulia F., Gitto E., Cuzzocrea S., Reiter R.J., Dugo L., Gitto P., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001, 31:343-349.
53. Leon J., Acuna-Castroviejo D., Escames G., Tan D.X., Reiter R.J. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005, 38:1-9.
54. Leon J., Acuna-Castroviejo D., Sainz R.M., Mayo J.C., Tan D.X., Reiter R.J. Melatonin and mitochondrial function. Life Sci 2004, 75:765-790.
55. Gitto E., Karbownik M., Reiter R.J., Tan D.X., Cuzzocrea S., Chiurazzi P., et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001, 6:756-760.
56. Lai M.C., Huang L.T. The effects of early life stress on neuroendocrine and neurobehaviors: mechanisms and implications. Pediatr Neonatol 2011, 52:122-129.
57. Rasmussen D.D., Marck B.T., Boldt B.M., Yellon S.M., Matsumoto A.M. Suppression of hypothalamic pro-opiomelanocortin (POMC) gene expression by daily melatonin supplementation in aging rats. J Pineal Res 2003, 34:127-133.
58. Muñoz-Hoyos A., Rodriguez-Cabezas T., Molina-Carballo A., Martinez-Sempere J.J., Ruiz-Cosano C., Acuña-Castroviejo D. Melatonin concentration in the umbilical artery and vein in human preterm and term neonates and neonates with acute fetal distress. J Pineal Res 1992, 13:184-191.
59. Muñoz-Hoyos A., Bonillo-Perales A., Avila-Villegas R., González-Ripoll M., Uberos J., Florido-Navío J., et al. Melatonin levels during the first week of life and their relation with the antioxidant response in the perinatal period. Neonatology 2007, 92:209-216.
60. Saito S., Tachibana T., Choi Y.H., Denbow D.M., Furuse M. ICV melatonin reduces acute stress responses in neonatal chicks. Behav Brain Res 2005, 165:197-203.
61. Owens J.A., Witmans M. Sleep problems. Curr Probl Pediatr Adolesc Health Care 2004, 34:154-179.
62. Jan J.E., Freeman R.D., Fast D.K. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev Med Child Neurol 1999, 41:491-500.
63. Dodge N.N., Wilson G.A. Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol 2001, 16:581-584.
64. Jan J.E., Freeman R.D. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade?. Dev Med Child Neurol 2004, 46:776-782.
65. Guénolé F., Godbout R., Nicolas A., Franco P., Claustrat B., Baleyte J.M. Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. Sleep Med Rev 2011, 15:379-387.
66. Giannotti F., Cortesi F., Cerquiglini A., Bernabei P. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J Autism Dev Disord 2006, 36:741-752.
67. Garstang J., Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006, 32:585-589.
68. Paavonen E.J., WendtT Nieminen-von, Vanhala R., Aronen E.T., von Wendt L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol 2003, 13:83-95.
69. Wasdell M.B., Jan J.E., Bomben M.M., Freeman R.D., Rietveld W.J., Tai J., et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008, 44:57-64.
70. Richdale A.L. A descriptive analysis of sleep behaviour in children with fragile X. J Intellect Dev Disabil 2003, 28:135-144.
71. Wirojanan J., Jacquemont S., Diaz R., Bacalman S., Anders T.F., Hagerman R.J., et al. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med 2009, 5:145-150.
72. Banach M., Gurdziel E., Je{ogonek}drych M., Borowicz K.K. Melatonin in experimental seizures and epilepsy. Pharmacol Rep 2011, 63:1-11.
73. Acuña-Castroviejo D., Escames G., Macias M., Muñóz Hoyos A., Molina Carballo A., Arauzo M., et al. Cell protective role of melatonin in the brain. J Pineal Res 1995, 19:57-63.
74. Niles L.P., Pickering D.S., Arciszewski M.A. Effect of chronic melatonin administration of GABA and diazepam binding in rat brain. J Neurol Transm 1987, 70:117-124.
75. A receptor function by Mel1a and Mel1b receptors. Nat Neurosci 1999, 2:401-403.
76. Savina T.A., Balashowa O.A., Shchipakina T.G. Effect of chronic consumption of sodium valproate and melatonin on seizure activity in Krushinskii-Molodkina rats. Bull Exp Biol Med 2006, 142:601-604.
77. Borowicz K.K., Kamiñski R., Gasior M., Kleinrok Z., Czuczwar S.J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur Neuropsychopharmacol 1999, 9:185-190.
78. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., Riazi K., Ghahremani M.H., Dehpour A.R. Melatonin enhances the anticonvulsant and proconvulsant effects of morphine in mice: role for nitric oxide signaling pathway. Epilepsy Res 2007, 75:138-144.
79. Lima E., Cabral F.R., Cavalheiro E.A., Naffah-Mazzacoratti Mda G., Amado D. Melatonin administration after pilocarpine-induced status epilepticus: A new way to prevent or attenuate postlesion epilepsy?. Epilepsy Behav 2011, 20:607-612.
80. Yamamoto H., Tang H. Preventive effect of melatonin against cyanide-induced seizures and lipid peroxidation in mice. Neurosci Lett 1996, 207:89-92.
81. Lapin I.P., Mirzaev S.M., Ryzov I.V., Oxenkrug G.F. Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J Pineal Res 1998, 24:215-218.
82. Peled N., Shorer Z., Peled E., Pillar G. Melatonin's effect on seizures in children with severe neurologic deficit disorders. Epilepsia 2001, 42:1208-1210.
83. Gupta M., Aneja S., Kohli K. Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo controlled trial. Epilepsy Behav 2004, 5:316-321.
84. Paprocka J., Dec R., Jamroz E., Marszał E. Melatonin and childhood refractory epilepsy-a pilot study. Med Sci Monit 2010, 16:CR389-CR396.
85. Musshoff U., Riewenherm D., Berger E., Fauteck J.D., Speckmann E.J. Melatonin receptors in rat hippocampus: molecular and functional investigations. Hippocampus 2002, 12:165-173.
86. Stewart L.S., Leung L.S. Hippocampal melatonin receptors modulate seizure threshold. Epilepsia 2005, 46:473-480.
87. Sandyk R., Tsagas N., Anninos P.A. Melatonin as a proconvulsive hormone in humans. Int J Neurosci 1992, 63:125-135.
88. Gitto E., Romeo C., Reiter R.J., Impellizzeri P., Pesce S., Basile M., et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004, 39:184-189.
89. Samarkandi A., Naguib M., Riad W., Thalaj A., Alotibi W., Aldammas F., et al. Melatonin versus midazolam premedication in children: a double blind, placebo-controlled study. Eur J Anaesthesiol 2005, 22:189-196.
90. Johnson K., Page A., Williams H., Wassemer E., Whitehouse W. The use of melatonin as an alternative to sedation in uncooperative children undergoing an MRI examination. Clin Radiol 2002, 57:502-506.
91. Sánchez-Barceló E.J., Mediavilla M.D., Tan D.X., Reiter R.J. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010, 17:2070-2095.
92. Reiter R.J., Tan D.X., Paredes S.D., Fuentes-Broto L. Beneficial effects of melatonin in cardiovascular disease. Ann Med 2010, 42:276-285.
93. Paulis L., Simko F. Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res 2007, 56:671-684.
94. Tain Y.L., Huang L.T., Lin I.C., Lau Y.T., Lin C.Y. Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. J Pineal Res 2010, 49:390-398.
95. Tain Y.L., Kao Y.H., Hsieh C.S., Chen C.C., Sheen J.M., Lin I.C., et al. Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine. Free Radic Biol Med 2010, 49:1088-1098.
96. Huang L.T., Tiao M.M., Tain Y.L., Chen C.C., Hsieh C.S. Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr Res 2009, 65:176-180.